All Stories

  1. Myths and Verities in Protein Folding Theories. By Arieh Ben-Naim. World Scientific, 2015. Pp. 448. Hardback. Price GBP 45.00. ISBN 978-981-4725-98-9.

    Article • Acta Crystallographica Section D Structural Biology, August 2016, International Union of Crystallography

    Dr Michael Blaber

  2. Crystal structure of C117S mutant of human acidic fibroblast growth factor

    Article • March 2015, Protein Data Bank, Rutgers University

    Dr Michael Blaber

  3. Crystal structure of C117A mutant of human acidic fibroblast growth factor

    Article • March 2015, Protein Data Bank, Rutgers University

    Dr Michael Blaber

  4. Crystal structure of C117T mutant of human acidic fibroblast growth factor in sodium formate buffer

    Article • March 2015, Protein Data Bank, Rutgers University

    Dr Michael Blaber

  5. Crystal structure of C16A/K12V/C117V/P134V mutant of human acidic fibroblast growth factor

    Article • March 2015, Protein Data Bank, Rutgers University

    Dr Michael Blaber

  6. Crystal structure of C117T mutant of human acidic fibroblast growth factor in sodium citrate buffer

    Article • March 2015, Protein Data Bank, Rutgers University

    Dr Michael Blaber

  7. Crystal structure of C16T/K12V/C117V/P134V mutant of human acidic fibroblast growth factor

    Article • March 2015, Protein Data Bank, Rutgers University

    Dr Michael Blaber

  8. Crystal structure of K12V/C16S/C117V/P134V mutant of human acidic fibroblast growth factor

    Article • March 2015, Protein Data Bank, Rutgers University

    Dr Michael Blaber

  9. Structure of a highly acidic β-lactamase from the moderate halophileChromohalobactersp. 560 and the discovery of a Cs+-selective binding site

    Article • Acta Crystallographica Section D Biological Crystallography, February 2015, International Union of Crystallography

    Dr Michael Blaber, Dr Shigeki Arai

  10. Mutation Choice to Eliminate Buried Free Cysteines in Protein Therapeutics

    Article • Journal of Pharmaceutical Sciences, February 2015, Elsevier

    Dr Michael Blaber

  11. Structural basis for acceptor-substrate recognition of UDP-glucose: anthocyanidin 3-O-glucosyltransferase fromClitoria ternatea

    Article • Protein Science, January 2015, Wiley

    Dr Michael Blaber

  12. Crystal Structure of 6xTyr/PV2: de novo designed beta-trefoil architecture with symmetric primary structure (L22Y/L44Y/L64Y/L85Y/L108Y/L132Y, Primitive Version 2)

    Article • January 2015, Protein Data Bank, Rutgers University

    Dr Michael Blaber

  13. Crystal Structure of 6xTrp/PV2: de novo designed beta-trefoil architecture with symmetric primary structure (L22W/L44W/L64W/L85W/L108W/L132W his Primitive Version 2)

    Article • January 2015, Protein Data Bank, Rutgers University

    Dr Michael Blaber

  14. Specificity studies on Kallikrein-related peptidase 7 (KLK7) and effects of osmolytes and glycosaminoglycans on its peptidase activity

    Article • Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, January 2015, Elsevier

    Dr Michael Blaber

  15. Beta-trefoil designed by folding nucleus symmetric expansion (""Phifoil"")

    Article • December 2014, Protein Data Bank, Rutgers University

    Dr Michael Blaber

  16. A single aromatic core mutation converts a designed “primitive” protein from halophile to mesophile folding

    Article • Protein Science, October 2014, Wiley

    Dr Michael Blaber

  17. Evolution and Design of Protein Structure by Folding Nucleus Symmetric Expansion

    Article • Structure, October 2014, Elsevier

    Dr Michael Blaber

  18. Structural characteristics of alkaline phosphatase from the moderately halophilic bacterium Halomonas sp. 593

    Article • Acta Crystallographica Section D Biological Crystallography, February 2014, International Union of Crystallography

    Dr Michael Blaber, Dr Shigeki Arai

  19. Isomannide-Based Peptidomimetics as Inhibitors for Human Tissue Kallikreins 5 and 7

    Article • ACS Medicinal Chemistry Letters, February 2014, American Chemical Society (ACS)

    Dr Michael Blaber

  20. Symmetric Protein Architecture in Protein Design: Top-Down Symmetric Deconstruction

    Article • January 2014, Springer Science + Business Media

    Dr Michael Blaber

  21. Prebiotic protein design supports a halophile origin of foldable proteins

    Article • Frontiers in Microbiology, January 2014, Frontiers

    Dr Michael Blaber

  22. Kallikrein-related peptidase 6: A biomarker for traumatic brain injury in the rat

    Article • Brain Injury, November 2013, Taylor & Francis

    Dr Michael Blaber

  23. Kallikrein Cascades in Traumatic Spinal Cord Injury: In Vitro Evidence for Roles in Axonopathy and Neuron Degeneration

    Article • Journal of Neuropathology & Experimental Neurology, November 2013, Oxford University Press (OUP)

    Dr Michael Blaber

  24. Creation and structure determination of an artificial protein with three complete sequence repeats

    Article • Journal of Synchrotron Radiation, October 2013, International Union of Crystallography

    Dr Michael Blaber

  25. Kallikrein 6 signals through PAR1 and PAR2 to promote neuron injury and exacerbate glutamate neurotoxicity

    Article • Journal of Neurochemistry, May 2013, Wiley

    Dr Michael Blaber

  26. Symfoil-4V synthetic protein with T30E/T72E/T116E mutations, and delta His tag

    Article • May 2013, Protein Data Bank, Rutgers University

    Dr Michael Blaber

  27. Human tissue kallikreins 3 and 5 can act as plasminogen activator releasing active plasmin

    Article • Biochemical and Biophysical Research Communications, April 2013, Elsevier

    Dr Michael Blaber

  28. Simplified protein design biased for prebiotic amino acids yields a foldable, halophilic protein

    Article • Proceedings of the National Academy of Sciences, January 2013, Proceedings of the National Academy of Sciences

    Dr Michael Blaber

  29. Crystal structure of Symfoil-4P/PV2: de novo designed beta-trefoil architecture with symmetric primary structure, primitive version 2 (6xLeu / PV1)

    Article • January 2013, Protein Data Bank, Rutgers University

    Dr Michael Blaber

  30. Clinical significance and novel mechanism of action of kallikrein 6 in glioblastoma

    Article • Neuro-Oncology, January 2013, Oxford University Press (OUP)

    Dr Michael Blaber

  31. Activation profiles of human kallikrein-related peptidases by matrix metalloproteinases

    Article • Biological Chemistry, January 2013, De Gruyter

    Dr Michael Blaber

  32. Kallikrein-related Peptidase 6

    Article • January 2013, Elsevier

    Dr Michael Blaber

  33. Experimental support for the foldability-function tradeoff hypothesis: Segregation of the folding nucleus and functional regions in fibroblast growth factor-1

    Article • Protein Science, November 2012, Wiley

    Dr Michael Blaber

  34. Pharmacokinetic Properties of 2nd-Generation Fibroblast Growth Factor-1 Mutants for Therapeutic Application

    Article • PLoS ONE, November 2012, PLOS

    Dr Michael Blaber

  35. Structure and Function of ∆1-Tetrahydrocannabinolic Acid (THCA) Synthase, the Enzyme Controlling the Psychoactivity of Cannabis sativa

    Article • Journal of Molecular Biology, October 2012, Elsevier

    Dr Michael Blaber

  36. Protein design at the interface of the pre-biotic and biotic worlds

    Article • Archives of Biochemistry and Biophysics, October 2012, Elsevier

    Dr Michael Blaber

  37. Isomannide derivatives as new class of inhibitors for human kallikrein 7

    Article • Bioorganic & Medicinal Chemistry Letters, October 2012, Elsevier

    Dr Michael Blaber

  38. Designing proteins from simple motifs: opportunities in Top-Down Symmetric Deconstruction

    Article • Current Opinion in Structural Biology, August 2012, Elsevier

    Dr Michael Blaber

  39. Crystal structure of tetrahydrocannabinolic acid synthase from Cannabis sativa

    Article • July 2012, Protein Data Bank, Rutgers University

    Dr Michael Blaber

  40. Emergence of symmetric protein architecture from a simple peptide motif: evolutionary models

    Article • Cellular and Molecular Life Sciences, July 2012, Springer Science + Business Media

    Dr Michael Blaber

  41. Kallikrein 6 is a novel molecular trigger of reactive astrogliosis

    Article • Biological Chemistry, May 2012, De Gruyter

    Dr Michael Blaber

  42. Kallikrein 6 Regulates Early CNS Demyelination in a Viral Model of Multiple Sclerosis

    Article • Brain Pathology, March 2012, Wiley

    Dr Michael Blaber

  43. A structural mechanism for dimeric to tetrameric oligomer conversion inHalomonassp. nucleoside diphosphate kinase

    Article • Protein Science, March 2012, Wiley

    Dr Michael Blaber, Dr Shigeki Arai

  44. Substrate recognition mechanism of a glycosyltrehalose trehalohydrolase fromSulfolobus solfataricusKM1

    Article • Protein Science, February 2012, Wiley

    Dr Michael Blaber

  45. Crystal structure of Symfoil-4P/PV1: de novo designed beta-trefoil architecture with symmetric primary structure, primitive version 1

    Article • January 2012, Protein Data Bank, Rutgers University

    Dr Michael Blaber

  46. Crystal structure of Symfoil-4P/PV1: de novo designed beta-trefoil architecture with symmetric primary structure, primitive version 1

    Article • January 2012, Protein Data Bank, Rutgers University

    Dr Michael Blaber

  47. Crystal structure of K15R/E18D/Y22W/H41G/F44W/E51D/E53P/K57R/E60D/Y64W/H82G/F85W/E90D/E94P/K98R/E101D/Y108W/H129G/F132W/E137D Symfoil-4P: de novo designed beta-trefoil architecture with symmetric primary structure

    Article • January 2012, Protein Data Bank, Rutgers University

    Dr Michael Blaber

  48. Development of “second-generation” forms of FGF-1 for therapeutic application

    Article • Journal of Stem Cell Research & Therapy, January 2012, OMICS Publishing Group

    Dr Michael Blaber

  49. Expression and Function of the Kallikrein-Related Peptidase 6 in the Human Melanoma Microenvironment

    Article • Journal of Investigative Dermatology, November 2011, Elsevier

    Dr Michael Blaber

  50. Substrate specificity of kallikrein-related peptidase 13 activated by salts or glycosaminoglycans and a search for natural substrate candidates

    Article • Biochimie, October 2011, Elsevier

    Dr Michael Blaber

  51. Biological evaluation and docking studies of natural isocoumarins as inhibitors for human kallikrein 5 and 7

    Article • Bioorganic & Medicinal Chemistry Letters, October 2011, Elsevier

    Dr Michael Blaber

  52. A Polypeptide “Building Block” for the β-Trefoil Fold Identified by “Top-Down Symmetric Deconstruction”

    Article • Journal of Molecular Biology, April 2011, Elsevier

    Dr Michael Blaber

  53. Functional Role of Kallikrein 6 in Regulating Immune Cell Survival

    Article • PLoS ONE, March 2011, PLOS

    Dr Michael Blaber

  54. North American Brain Injury Societyʼs Ninth Annual Conference on Brain Injury

    Article • Journal of Head Trauma Rehabilitation, January 2011, Wolters Kluwer Health

    Dr Michael Blaber

  55. Experimental support for the evolution of symmetric protein architecture from a simple peptide motif

    Article • Proceedings of the National Academy of Sciences, December 2010, Proceedings of the National Academy of Sciences

    Dr Michael Blaber

  56. Substrate specificity and inhibition of human kallikrein-related peptidase 3 (KLK3 or PSA) activated with sodium citrate and glycosaminoglycans

    Article • Archives of Biochemistry and Biophysics, June 2010, Elsevier

    Dr Michael Blaber

  57. Functional intersection of the kallikrein-related peptidases (KLKs) and thrombostasis axis

    Article • Biological Chemistry, April 2010, De Gruyter

    Dr Michael Blaber

  58. T4 Lysozyme S44E/WT*

    Article • January 2010, Protein Data Bank, Rutgers University

    Dr Michael Blaber

  59. Analysis of the Dynamics of Assembly and Structural Impact for a Histidine Tagged FGF1−1.5 nm Au Nanoparticle Bioconjugate

    Article • Bioconjugate Chemistry, November 2009, American Chemical Society (ACS)

    Dr Michael Blaber

  60. X-ray structure and biophysical properties of rabbit fibroblast growth factor 1

    Article • Acta Crystallographica Section F Structural Biology and Crystallization Communications, October 2009, International Union of Crystallography

    Dr Michael Blaber

  61. Engineering an improved crystal contact across a solvent-mediated interface of human fibroblast growth factor 1

    Article • Acta Crystallographica Section F Structural Biology and Crystallization Communications, October 2009, International Union of Crystallography

    Dr Michael Blaber

  62. Structural Basis of Conserved Cysteine in the Fibroblast Growth Factor Family: Evidence for a Vestigial Half-Cystine

    Article • Journal of Molecular Biology, October 2009, Elsevier

    Dr Michael Blaber

  63. The Interaction between Thermodynamic Stability and Buried Free Cysteines in Regulating the Functional Half-Life of Fibroblast Growth Factor-1

    Article • Journal of Molecular Biology, October 2009, Elsevier

    Dr Michael Blaber

  64. Alternative type I and I′ turn conformations in the β8/β9 β-hairpin of human acidic fibroblast growth factor

    Article • Protein Science, April 2009, Wiley

    Dr Michael Blaber

  65. Structure and stability effects of mutations designed to increase the primary sequence symmetry within the core region of a β-trefoil

    Article • Protein Science, April 2009, Wiley

    Dr Michael Blaber

  66. A completed KLK activome profile: investigation of activation profiles of KLK9, 10, and 15

    Article • Biological Chemistry, April 2009, De Gruyter

    Dr Michael Blaber

  67. S1′ and S2′ subsite specificities of human plasma kallikrein and tissue kallikrein 1 for the hydrolysis of peptides derived from the bradykinin domain of human kininogen

    Article • Biological Chemistry, December 2008, De Gruyter

    Dr Michael Blaber

  68. Activation profiles of human kallikrein-related peptidases by proteases of the thrombostasis axis

    Article • Protein Science, November 2008, Wiley

    Dr Michael Blaber

  69. Protease-activated receptor dependent and independent signaling by kallikreins 1 and 6 in CNS neuron and astroglial cell lines

    Article • Journal of Neurochemistry, November 2008, Wiley

    Dr Michael Blaber

  70. Development of Hydrogen and Hydration Database for Biomolecules (HHDB)

    Article • Acta Crystallographica Section A Foundations of Crystallography, August 2008, International Union of Crystallography

    Dr Michael Blaber

  71. Kallikreins are associated with secondary progressive multiple sclerosis and promote neurodegeneration

    Article • Biological Chemistry, June 2008, De Gruyter

    Dr Michael Blaber

  72. Mutagenesis of the crystal contact of acidic fibroblast growth factor

    Article • Journal of Synchrotron Radiation, April 2008, International Union of Crystallography

    Dr Michael Blaber

  73. A Logical OR Redundancy within the Asx-Pro-Asx-Gly Type I β-Turn Motif

    Article • Journal of Molecular Biology, April 2008, Elsevier

    Dr Michael Blaber

  74. Substrate specificity of human kallikreins 1 and 6 determined by phage display

    Article • Protein Science, April 2008, Wiley

    Dr Michael Blaber

  75. Activation Profiles and Regulatory Cascades of the Human Kallikrein-related Peptidases

    Article • Journal of Biological Chemistry, August 2007, American Society for Biochemistry & Molecular Biology (ASBMB)

    Dr Michael Blaber

  76. Spackling the Crack: Stabilizing Human Fibroblast Growth Factor-1 by Targeting the N and C terminus β-Strand Interactions

    Article • Journal of Molecular Biology, August 2007, Elsevier

    Dr Michael Blaber

  77. The Autolytic Regulation of Human Kallikrein-Related Peptidase 6†

    Article • Biochemistry, May 2007, American Chemical Society (ACS)

    Dr Michael Blaber

  78. Proteinase-activated Receptors, Targets for Kallikrein Signaling

    Article • Journal of Biological Chemistry, September 2006, American Society for Biochemistry & Molecular Biology (ASBMB)

    Dr Michael Blaber

  79. Potential scope of action of tissue kallikreins in CNS immune-mediated disease

    Article • Journal of Neuroimmunology, September 2006, Elsevier

    Dr Michael Blaber

  80. Dynamic role of kallikrein 6 in traumatic spinal cord injury

    Article • European Journal of Neuroscience, September 2006, Wiley

    Dr Michael Blaber

  81. Kallikrein-mediated cell signalling: targeting proteinase-activated receptors (PARs)

    Article • Biological Chemistry, January 2006, De Gruyter

    Dr Michael Blaber

  82. A comprehensive nomenclature for serine proteases with homology to tissue kallikreins

    Article • Biological Chemistry, January 2006, De Gruyter

    Dr Michael Blaber

  83. Substrate Specificity of Human Kallikrein 6: SALT AND GLYCOSAMINOGLYCAN ACTIVATION EFFECTS

    Article • Journal of Biological Chemistry, December 2005, American Society for Biochemistry & Molecular Biology (ASBMB)

    Dr Michael Blaber

  84. Redesigning symmetry-related “mini-core” regions of FGF-1 to increase primary structure symmetry: Thermodynamic and functional consequences of structural symmetry

    Article • Protein Science, September 2005, Wiley

    Dr Michael Blaber

  85. Hydrogen and hydration database for bio-macromolecules (HHDB)

    Article • Acta Crystallographica Section A Foundations of Crystallography, August 2005, International Union of Crystallography

    Dr Michael Blaber

  86. Structural and Energetic Consequences of Mutations in a Solvated Hydrophobic Cavity

    Article • Journal of Molecular Biology, February 2005, Elsevier

    Dr Michael Blaber

  87. 1.70 Å X-ray structure of human apo kallikrein 1: Structural changes upon peptide inhibitor/substrate binding

    Article • Proteins Structure Function and Bioinformatics, January 2005, Wiley

    Dr Michael Blaber

  88. Symmetric Primary and Tertiary Structure Mutations within a Symmetric Superfold: A Solution, not a Constraint, to Achieve a Foldable Polypeptide

    Article • Journal of Molecular Biology, November 2004, Elsevier

    Dr Michael Blaber

  89. Distinct promoters regulate tissue-specific and differential expression of kallikrein 6 in CNS demyelinating disease

    Article • Journal of Neurochemistry, October 2004, Wiley

    Dr Michael Blaber

  90. An atomic resolution structure for human fibroblast growth factor 1

    Article • Proteins Structure Function and Bioinformatics, July 2004, Wiley

    Dr Michael Blaber

  91. Targeting kallikrein 6‐proteolysis attenuates CNS inflammatory disease

    Article • The FASEB Journal, March 2004, Wiley

    Dr Michael Blaber

  92. Nano-dynamics: engineering allostery via tandem duplication and turn energetics

    Article • Trends in Biotechnology, January 2004, Elsevier

    Dr Michael Blaber

  93. Accommodation of a highly symmetric core within a symmetric protein superfold

    Article • Protein Science, December 2003, Wiley

    Dr Michael Blaber

  94. Identification of a Key Structural Element for Protein Folding Within β-Hairpin Turns

    Article • Journal of Molecular Biology, May 2003, Elsevier

    Dr Michael Blaber

  95. Structural Biology of the Aldo-Keto Reductase Family of Enzymes: Catalysis and Cofactor Binding

    Article • Cell Biochemistry and Biophysics, January 2003, Springer Science + Business Media

    Dr Michael Blaber

  96. Crystal Structure and Biochemical Characterization of Human Kallikrein 6 Reveals That a Trypsin-like Kallikrein Is Expressed in the Central Nervous System

    Article • Journal of Biological Chemistry, April 2002, American Society for Biochemistry & Molecular Biology (ASBMB)

    Dr Michael Blaber

  97. Enzymatic Properties of Rat Myelencephalon-Specific Protease †

    Article • Biochemistry, January 2002, American Chemical Society (ACS)

    Dr Michael Blaber

  98. Structural assembly of the active site in an aldo-keto reductase by NADPH cofactor

    Article • Journal of Molecular Biology, June 2001, Elsevier

    Dr Michael Blaber

  99. Thermodynamic Characterization of Mutants of Human Fibroblast Growth Factor 1 with an Increased Physiological Half-Life†

    Article • Biochemistry, June 2000, American Chemical Society (ACS)

    Dr Michael Blaber

  100. Preferential expression of myelencephalon-specific protease by oligodendrocytes of the adult rat spinal cord white matter

    Article • Glia, May 2000, Wiley

    Dr Michael Blaber

  101. Molecular modeling of substrate binding in wild-type and mutantCorynebacteria 2,5-diketo-D-gluconate reductases

    Article • Proteins Structure Function and Bioinformatics, April 2000, Wiley

    Dr Michael Blaber

  102. Reversible Thermal Denaturation of Human FGF-1 Induced by Low Concentrations of Guanidine Hydrochloride

    Article • Biophysical Journal, July 1999, Elsevier

    Dr Michael Blaber

  103. Disordered water within a hydrophobic protein cavity visualized by x-ray crystallography

    Article • Proceedings of the National Academy of Sciences, January 1999, Proceedings of the National Academy of Sciences

    Dr Michael Blaber

  104. Crystal structure of 2,5-diketo- d -gluconic acid reductase A complexed with NADPH at 2.1-Å resolution

    Article • Proceedings of the National Academy of Sciences, June 1998, Proceedings of the National Academy of Sciences

    Dr Michael Blaber

  105. Biophysical and structural analysis of human acidic fibroblast growth factor

    Article • January 1997, Elsevier

    Dr Michael Blaber

  106. X-ray Crystal Structure of Human Acidic Fibroblast Growth Factor † , ‡

    Article • Biochemistry, January 1996, American Chemical Society (ACS)

    Dr Michael Blaber

  107. Alanine Scanning Mutagenesis of the α-Helix 115-123 of Phage T4 Lysozyme: Effects on Structure, Stability and the Binding of Solvent

    Article • Journal of Molecular Biology, February 1995, Elsevier

    Dr Michael Blaber

  108. 2.0 ANGSTROM STRUCTURE OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR

    Article • June 1994, Protein Data Bank, Rutgers University

    Dr Michael Blaber

  109. Accommodation of Amino Acid Insertions in an α-Helix of T4 Lysozyme

    Article • Journal of Molecular Biology, February 1994, Elsevier

    Dr Michael Blaber

  110. Determination of α-Helix Propensity within the Context of a Folded Protein

    Article • Journal of Molecular Biology, January 1994, Elsevier

    Dr Michael Blaber

  111. Response

    Article • Science, November 1993, American Association for the Advancement of Science

    Dr Michael Blaber

  112. STRUCTURAL BASIS OF ALPHA-HELIX PROPENSITY AT TWO SITES IN T4 LYSOZYME

    Article • October 1993, Protein Data Bank, Rutgers University

    Dr Michael Blaber

  113. Energetic cost and structural consequences of burying a hydroxyl group within the core of a protein determined from Ala .fwdarw. Ser and Val .fwdarw. Thr substitutions in T4 lysozyme

    Article • Biochemistry, October 1993, American Chemical Society (ACS)

    Dr Michael Blaber

  114. Synthetic chimeras of mouse growth factor-associated glandular kallikreins. II. Growth factor binding properties

    Article • Protein Science, August 1993, Wiley

    Dr Michael Blaber

  115. Synthetic chimeras of mouse growth factor-associated glandular kallikreins. I. Kinetic properties

    Article • Protein Science, August 1993, Wiley

    Dr Michael Blaber

  116. Prediction of the three-dimensional structures of the nerve growth factor and epidermal growth factor binding proteins (kallikreins) and an hypothetical structure of the high molecular weight complex of epidermal growth factor with its binding protein

    Article • Protein Science, August 1993, Wiley

    Dr Michael Blaber

  117. Structural basis of amino acid alpha helix propensity

    Article • Science, June 1993, American Association for the Advancement of Science

    Dr Michael Blaber

  118. Response

    Article • Science, January 1993, American Association for the Advancement of Science

    Dr Michael Blaber

  119. Response of a protein structure to cavity-creating mutations and its relation to the hydrophobic effect

    Article • Science, January 1992, American Association for the Advancement of Science

    Dr Michael Blaber

  120. Dissection of protein structure and folding by directed mutagenesis

    Article • Faraday Discussions, January 1992, Royal Society of Chemistry

    Dr Michael Blaber

  121. The characterization of recombinant mouse glandular kallikreins fromE. coli

    Article • Proteins Structure Function and Bioinformatics, January 1990, Wiley

    Dr Michael Blaber

  122. Chapter 13 Neurotrophic factors in the CNS: biosynthetic processing and functional responses

    Article • January 1990, Elsevier

    Dr Michael Blaber

  123. Substrate specificities of growth factor associated kallikreins of the mouse submandibular gland

    Article • Biochemistry, September 1989, American Chemical Society (ACS)

    Dr Michael Blaber

  124. A complete cDNA sequence for the major epidermal growth factor binding protein in the male mouse submandibular gland

    Article • Biochemistry, October 1987, American Chemical Society (ACS)

    Dr Michael Blaber

  125. Epidermal growth factor binding protein: identification of a different protein

    Article • Biochemistry, April 1987, American Chemical Society (ACS)

    Dr Michael Blaber

  126. Complete nucleotide sequence of the Escherichia coli gene encoding malate dehydrogenase

    Article • Nucleic Acids Research, January 1987, Oxford University Press (OUP)

    Dr Michael Blaber

  127. Purification and characterization of recombinant single-chain urokinase produced in Escherichia coli

    Article • Biochemistry, July 1986, American Chemical Society (ACS)

    Dr Michael Blaber

  128. Purification and Characterization of Recombinant Urokinase from Escherichia coli

    Article • Nature Biotechnology, November 1985, Springer Science + Business Media

    Dr Michael Blaber

  129. Cloning and Expression of the Gene for Pro-urokinase in Escherichia coli

    Article • Biotechnology, October 1985, Springer Science + Business Media

    Dr Michael Blaber